Inventor · disambiguated record
Taishan Hu
Also filed as: Hu taishan
23 granted patents·9 pending applications·89 citations·filing 2013–2023
93Inventor score
Top patents by PatentIndex Score
32 records- 0194US9447086B26-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2013·Granted Sep 20, 2016·34 cites·5 claims
- 0293US9233978B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Jan 12, 2016·18 cites·23 claims
- 0390US10081627B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Sep 25, 2018·9 cites·30 claims
- 0489US10428069B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Oct 1, 2019·6 cites·21 claims
- 0588US11098080B2Peptide macrocycles against Acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2018·Granted Aug 24, 2021·3 cites·16 claims
- 0684US10030047B2Peptide macrocycles against acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2016·Granted Jul 24, 2018·2 cites·51 claims
- 0783US9890167B2Pyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2016·Granted Feb 13, 2018·4 cites·50 claims
- 0880US11505573B2Peptide macrocycles against Acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2019·Granted Nov 22, 2022·2 cites·26 claims
- 0980US9266904B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2014·Granted Feb 23, 2016·5 cites·23 claims
- 1079US9758530B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Sep 12, 2017·3 cites·14 claims
- 1174US12351575B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2019·Granted Jul 8, 2025·0 cites·13 claims
- 1274US11384097B2Tetrahydroisoquinoline derivative, preparation method therefor and use thereofZHEJIANG HISUN PHARM CO LTD·Filed 2019·Granted Jul 12, 2022·2 cites·19 claims
- 1374US10562905B2Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Feb 18, 2020·1 cites·6 claims
- 1471US2024050516A1Peptide macrocycles against acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1568US12012466B2Peptide macrocycles against Acinetobacter baumanniiHOFFMANN LA ROCHE·Filed 2021·Granted Jun 18, 2024·0 cites·5 claims
- 1657US2024317748A1Carbonyl substituted diazaspiro compounds and its useBIONOVA PHARMACEUTICALS SHANGHAI LTD·Filed 2022·Application pending·0 cites
- 1757US2020181156A1Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1852US12252484B2Pyrazolopyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Mar 18, 2025·0 cites·17 claims
- 1952US10683299B2Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Jun 16, 2020·0 cites·12 claims
- 2052US2022395496A1Piperidinyl amine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2152US2021269451A1Pyridinyl heterocyclyl compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2250US11168086B2Methods of synthesizing pyrazine compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Nov 9, 2021·0 cites·20 claims
- 2349US10604527B2Pyrazine compounds for the treatment of hepatitis B infectionHOFFMANN LA ROCHE·Filed 2018·Granted Mar 31, 2020·0 cites·15 claims
- 2449US2023295163A1Tetracyclic derivative, method for preparing same and use thereof in medicineZHEJIANG HISUN PHARM CO LTD·Filed 2021·Application pending·0 cites
- 2549US2023373972A1Piperazine derivative, preparation method therefor and use thereofZHEJIANG HISUN PHARM CO LTD·Filed 2021·Application pending·0 cites
- 2647US12447151B2Alkyne derivative, preparation method for same, and uses thereofZHEJIANG HISUN PHARM CO LTD·Filed 2020·Granted Oct 21, 2025·0 cites·9 claims
- 2746US10781206B2Tetrahydropyrazolopyridine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Sep 22, 2020·0 cites·17 claims
- 2845US2023348467A1Heteroaryl Derivative, Preparation Method Therefor, And Use ThereofZHEJIANG HISUN PHARM CO LTD·Filed 2021·Application pending·0 cites
- 2944US12410191B2Macrolide derivatives, preparation method and application thereofZHEJIANG HISUN PHARM CO LTD·Filed 2020·Granted Sep 9, 2025·0 cites·18 claims
- 3044US2022112187A1Pyrazolopyridine amine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3143US12234222B2Piperazine amide derivative, preparation method therefor, and use thereof in medicineZHEJIANG HISUN PHARM CO LTD·Filed 2020·Granted Feb 25, 2025·0 cites·14 claims
- 3242US11897863B2Indazole amine derivative, preparation method therefor and medical use thereofZHEJIANG HISUN PHARM CO LTD·Filed 2019·Granted Feb 13, 2024·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Taishan Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →